phenylethyl alcohol has been researched along with Diabetic Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Chang, X; Chen, F; Chen, X; Gong, P; Pi, S; Wang, L; Wen, H; Yang, W | 1 |
1 other study(ies) available for phenylethyl alcohol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Metabolomics study of cadmium-induced diabetic nephropathy and protective effect of caffeic acid phenethyl ester using UPLC-Q-TOF-MS combined with pattern recognition.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arachidonic Acid; Cadmium; Caffeic Acids; Catalase; Diabetic Nephropathies; Glutathione; Kidney; Lipid Metabolism; Male; Metabolomics; Mice; Oxidative Stress; Pattern Recognition, Automated; Phenylethyl Alcohol; Superoxide Dismutase; Tandem Mass Spectrometry | 2017 |